{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:27:12Z","timestamp":1787790432325,"version":"build-2784847793"},"reference-count":59,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Older adults are increasingly prescribed medications that have adverse effects. Prior studies have found a higher risk of motor vehicle crashes to be associated with certain medication use.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine whether specific medication classes were associated with performance decline as assessed by a standardized road test in a community sample of cognitively healthy older adults, to evaluate additional associations of poor road test performance with comorbid medical conditions and demographic characteristics, and to test the hypothesis that specific medication classes (ie, antidepressants, benzodiazepines, sedatives or hypnotics, anticholinergics, antihistamines, and nonsteroidal anti-inflammatory drugs or acetaminophen) would be associated with an increase in risk of impaired driving performance over time.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This was a prospective cohort study of 198 cognitively healthy adults 65 years and older with a valid driver\u2019s license who were followed up annually, with rolling enrollment. Data were collected from participants in St Louis, Missouri, and neighboring Illinois who were enrolled in the Knight Alzheimer\u2019s Disease Research Center. Data were collected from August 28, 2012, to March 14, 2023, and analyzed from April 1 to 25, 2023. Participants with healthy cognition, defined as a Clinical Dementia Rating score of 0 at baseline and subsequent visits, who had available clinical, neuropsychological, road tests, and self-reported medication data were included.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Potentially driver-impairing medication use.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome measure was performance on the Washington University Road Test (pass or marginal\/fail). Multivariable Cox proportional hazards models were used to evaluate associations between potentially driver-impairing medication use and road test performance.<\/jats:p><\/jats:sec>Results<\/jats:title>Of the 198 included adults (mean [SD] baseline age, 72.6 [4.6] years; 87 female [43.9%]), 70 (35%) received a marginal\/fail rating on the road test over a mean (SD) follow-up of 5.70 (2.45) years. Any use of antidepressants (adjusted hazard ratio [aHR], 2.68; 95% CI, 1.69-4.71), serotonin and norepinephrine reuptake inhibitors (aHR, 2.68; 95% CI, 1.54-4.64), sedatives or hypnotics (aHR, 2.70; 95% CI, 1.40-5.19), or nonsteroidal anti-inflammatory drugs (aHR, 2.72; 95% CI, 1.31-5.63) was associated with an increase in risk of receiving a marginal\/fail rating on the road test compared with control individuals. Conversely, participants taking lipid-lowering agents had a lower risk of receiving a marginal\/fail rating compared to control individuals. There were no statistically significant associations found between anticholinergic or antihistamines and poor performance.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this prospective cohort study, specific medication classes were associated with an increase in risk of poor road test performance over time. Clinicians should consider this information and counsel patients accordingly when prescribing these medications.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.35651","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T15:33:41Z","timestamp":1696001621000},"page":"e2335651","source":"Crossref","is-referenced-by-count":15,"title":["Medication and Road Test Performance Among Cognitively Healthy Older Adults"],"prefix":"10.1001","volume":"6","author":[{"given":"David B.","family":"Carr","sequence":"first","affiliation":[{"name":"Department of Medicine, Washington University in St Louis, St Louis, Missouri"},{"name":"Department of Neurology, Washington University in Saint Louis School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebede","family":"Beyene","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Administrative Sciences, University of Health Sciences and Pharmacy in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Doherty","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in Saint Louis School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in Saint Louis School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Center for Clinical Studies, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailee","family":"Domash","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in Saint Louis School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Riley","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in Saint Louis School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in Saint Louis School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Sabapathy","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in Saint Louis School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in Saint Louis School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh M.","family":"Babulal","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in Saint Louis School of Medicine, St Louis, Missouri"},{"name":"Institute of Public Health, Washington University School of Medicine, St Louis, Missouri"},{"name":"Department of Psychology, Faculty of Humanities, University of Johannesburg, Johannesburg, South Africa"},{"name":"Department of Clinical Research and Leadership, The George Washington University School of Medicine and Health Sciences, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"issue":"4","key":"zoi231024r1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/geriatrics5040085","article-title":"Multi-morbidity and polypharmacy in older people: challenges and opportunities for clinical practice.","volume":"5","author":"Aggarwal","year":"2020","journal-title":"Geriatrics (Basel)"},{"key":"zoi231024r3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jsr.2019.09.019","article-title":"Driver licensing, motor-vehicle crashes, and moving violations among older adults.","volume":"71","author":"Palumbo","year":"2019","journal-title":"J Safety Res"},{"issue":"8","key":"zoi231024r4","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/01634372.2019.1663460","article-title":"Older adults\u2019 expectations about mortality, driving life and years left without driving.","volume":"62","author":"Babulal","year":"2019","journal-title":"J Gerontol Soc Work"},{"issue":"1","key":"zoi231024r6","doi-asserted-by":"publisher","DOI":"10.1093\/geroni\/igab051","article-title":"Driving performance in older adults: current measures, findings, and implications for roadway safety.","volume":"6","author":"Toups","year":"2022","journal-title":"Innov Aging"},{"key":"zoi231024r9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.aap.2015.06.012","article-title":"Why have fatality rates among older drivers declined? the relative contributions of changes in survivability and crash involvement.","volume":"83","author":"Cicchino","year":"2015","journal-title":"Accid Anal Prev"},{"issue":"16","key":"zoi231024r10","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/jama.2010.481","article-title":"The older adult driver with cognitive impairment: \u201cit\u2019s a very frustrating life\u201d.","volume":"303","author":"Carr","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"zoi231024r12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1559827615609050","article-title":"Potentially driver-impairing medications: risks and strategies for injury prevention.","volume":"10","author":"Ivers","year":"2016","journal-title":"Am J Lifestyle Med"},{"issue":"4","key":"zoi231024r13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/1060028014520882","article-title":"Medications and impaired driving.","volume":"48","author":"Hetland","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"1","key":"zoi231024r14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12877-021-02726-5","article-title":"Use of potentially driver-impairing drugs among older drivers.","volume":"22","author":"Zitoun","year":"2022","journal-title":"BMC Geriatr"},{"issue":"9","key":"zoi231024r15","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/jgs.2016.64.issue-9","article-title":"Cognitive tests and determining fitness to drive in dementia: a systematic review.","volume":"64","author":"Bennett","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"zoi231024r16","doi-asserted-by":"publisher","first-page":"e906","DOI":"10.1212\/WNL.0000000000006132","article-title":"Driving impairment and crash risk in Parkinson disease: a systematic review and meta-analysis.","volume":"91","author":"Thompson","year":"2018","journal-title":"Neurology"},{"issue":"8","key":"zoi231024r17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1212\/WNL.0b013e31820d6300","article-title":"Screening for fitness to drive after stroke: a systematic review and meta-analysis.","volume":"76","author":"Devos","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"zoi231024r18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/HTR.0b013e3182236299","article-title":"Prediction of driving capacity after traumatic brain injury: a systematic review.","volume":"27","author":"Ortoleva","year":"2012","journal-title":"J Head Trauma Rehabil"},{"issue":"1","key":"zoi231024r19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/geriatrics3010012","article-title":"Driving outcomes among older adults: a systematic review on racial and ethnic differences over 20 years.","volume":"3","author":"Babulal","year":"2018","journal-title":"Geriatrics (Basel)"},{"issue":"2","key":"zoi231024r20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s40615-019-00655-z","article-title":"Differences in driving outcomes among cognitively normal African American and Caucasian older adults.","volume":"7","author":"Babulal","year":"2020","journal-title":"J Racial Ethn Health Disparities"},{"issue":"4","key":"zoi231024r21","first-page":"270","article-title":"The national Alzheimer\u2019s coordinating center (NACC) database: an Alzheimer disease database.","volume":"18","author":"Beekly","year":"2004","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"zoi231024r22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","article-title":"The National Alzheimer\u2019s Coordinating Center (NACC) database: the uniform data set.","volume":"21","author":"Beekly","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"zoi231024r23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/0733464817690679","article-title":"A naturalistic study of driving behavior in older adults and preclinical Alzheimer disease: a pilot study.","volume":"38","author":"Babulal","year":"2019","journal-title":"J. Appl Gerontol"},{"issue":"11","key":"zoi231024r24","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules.","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"11","key":"zoi231024r25","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1111\/j.1532-5415.2011.03657.x","article-title":"Predicting road test performance in drivers with dementia.","volume":"59","author":"Carr","year":"2011","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"zoi231024r26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.trci.2016.11.006","article-title":"Preclinical Alzheimer\u2019s disease and longitudinal driving decline.","volume":"3","author":"Roe","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"issue":"6","key":"zoi231024r27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/archneur.1997.00550180029008","article-title":"Reliability of the Washington University road test. a performance-based assessment for drivers with dementia of the Alzheimer type.","volume":"54","author":"Hunt","year":"1997","journal-title":"Arch Neurol"},{"issue":"12","key":"zoi231024r28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167751","article-title":"Association of functional impairments and co-morbid conditions with driving performance among cognitively normal older adults.","volume":"11","author":"Carr","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"zoi231024r29","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1046\/j.1532-5415.2003.51481.x","article-title":"Longitudinal driving performance in early-stage dementia of the Alzheimer type.","volume":"51","author":"Duchek","year":"2003","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"zoi231024r30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"6","key":"zoi231024r31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"4","key":"zoi231024r32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/01.wad.0000213865.09806.92","article-title":"The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.","volume":"20","author":"Morris","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"zoi231024r35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1177\/1060028014520881","article-title":"Potentially driver-impairing (PDI) medication use in medically impaired adults referred for driving evaluation.","volume":"48","author":"Hetland","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"1","key":"zoi231024r36","doi-asserted-by":"publisher","first-page":"i-48","DOI":"10.1037\/h0093567","article-title":"An analysis of certain psychological tests used for the evaluation of brain injury.","volume":"60","author":"Armitage","year":"1946","journal-title":"Psychol Monogr"},{"issue":"6","key":"zoi231024r37","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/WNL.38.6.900","article-title":"Screening for dementia by memory testing.","volume":"38","author":"Grober","year":"1988","journal-title":"Neurology"},{"issue":"2","key":"zoi231024r38","first-page":"167","article-title":"Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming.","volume":"14","author":"Tombaugh","year":"1999","journal-title":"Arch Clin Neuropsychol"},{"issue":"8","key":"zoi231024r39","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol"},{"issue":"6","key":"zoi231024r40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1212\/01.wnl.0000341931.35870.49","article-title":"Predictors of driving safety in early Alzheimer disease.","volume":"72","author":"Dawson","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"zoi231024r41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40615-022-01238-1","article-title":"The effects of race\/ethnicity, age, and area deprivation index (ADI) on COVID-19 disease early dynamics: Washington, DC, case study.","volume":"10","author":"Adjei-Fremah","year":"2023","journal-title":"J Racial Ethn Health Disparities"},{"issue":"1","key":"zoi231024r42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.trci.2016.11.006","article-title":"Preclinical Alzheimer\u2019s disease and longitudinal driving decline.","volume":"3","author":"Roe","year":"2017","journal-title":"Alzheimer's Dement: Transl Res Clin"},{"issue":"446","key":"zoi231024r43","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"8","key":"zoi231024r44","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.4088\/JCP.11m07624","article-title":"Risk of injurious road traffic crash after prescription of antidepressants.","volume":"73","author":"Orriols","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"zoi231024r45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40621-017-0107-x","article-title":"Depression, antidepressants and driving safety.","volume":"4","author":"Hill","year":"2017","journal-title":"Inj Epidemiol"},{"issue":"8","key":"zoi231024r46","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1007\/s00213-022-06146-0","article-title":"Use of psychotropic medication and risk of road traffic crashes: a registry-based case-control study in Denmark, 1996-2018.","volume":"239","author":"Olesen","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"zoi231024r47","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.2105\/AJPH.2015.302723","article-title":"Sedative hypnotic medication use and the risk of motor vehicle crash.","volume":"105","author":"Hansen","year":"2015","journal-title":"Am J Public Health"},{"issue":"5","key":"zoi231024r48","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cellsig.2004.12.007","article-title":"Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways.","volume":"17","author":"Taylor","year":"2005","journal-title":"Cell Signal"},{"key":"zoi231024r49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/00023210-199503040-00002","article-title":"Avoiding and managing anticholinergic effects of antidepressants.","volume":"3","author":"Riedel","year":"1995","journal-title":"CNS Drugs"},{"issue":"6","key":"zoi231024r50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/107839039600200606","article-title":"Antidepressants and the cytochrome P450 enzymes.","volume":"2","author":"Glod","year":"1996","journal-title":"J Am Psychiatr Nurses Assoc"},{"issue":"9","key":"zoi231024r51","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"1-s","key":"zoi231024r52","doi-asserted-by":"publisher","first-page":"442","DOI":"10.22270\/jddt.v9i1-s.2287","article-title":"Non-steroidal anti-inflammatory drugs: an overview.","volume":"9","author":"Jahnavi","year":"2019","journal-title":"J Drug Deliv Ther"},{"issue":"9","key":"zoi231024r53","first-page":"24","article-title":"Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults.","volume":"18","author":"Marcum","year":"2010","journal-title":"Ann Longterm Care"},{"issue":"Suppl 1","key":"zoi231024r54","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.2459\/JCM.0000000000000443","article-title":"NSAIDs and cardiovascular risk.","volume":"18","author":"Marsico","year":"2017","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"15","key":"zoi231024r55","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.108.824151","article-title":"Statin adherence and risk of accidents: a cautionary tale.","volume":"119","author":"Dormuth","year":"2009","journal-title":"Circulation"},{"key":"zoi231024r56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-018-0110-3","article-title":"The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms.","volume":"7","author":"Schultz","year":"2018","journal-title":"Transl Neurodegener"},{"issue":"6","key":"zoi231024r57","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/gerona\/glz147","article-title":"Multimorbidity and cognitive decline over 14 years in older Americans.","volume":"75","author":"Wei","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"zoi231024r58","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/jgs.v68.5","article-title":"Multimorbidity in Medicare beneficiaries: performance of an ICD-coded multimorbidity-weighted index.","volume":"68","author":"Wei","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"zoi231024r59","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.2015.63.issue-11","article-title":"American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults.","volume":"63","author":"American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"zoi231024r2","unstructured":"Insurance Institute for Highway Safety. Older drivers. Accessed August 29, 2023. https:\/\/www.iihs.org\/topics\/older-drivers"},{"key":"zoi231024r5","unstructured":"American Automobile Association Foundation for Traffic Safety. Rates of motor vehicle crashes, injuries and deaths in relation to driver age, United States, 2014-2015. Accessed August 29, 2023. https:\/\/aaafoundation.org\/rates-motor-vehicle-crashes-injuries-deaths-relation-driver-age-united-states-2014-2015\/"},{"key":"zoi231024r7","unstructured":"Insurance Institute for Highway Safety. Fatality facts 2020: older people. Accessed August 29, 2023. https:\/\/www.iihs.org\/topics\/fatality-statistics\/detail\/older-people"},{"key":"zoi231024r8","unstructured":"US Centers for Disease Control Prevention. 10 Leading causes of injury deaths by age group. Accessed April 20, 2023. https:\/\/www.cdc.gov\/injury\/wisqars\/pdf\/Leading-Causes-of-Injury-Deaths-by-Age-Group_2020_508.pdf"},{"key":"zoi231024r11","unstructured":"LeRoy? A, Morse? MM. Multiple medications and vehicle crashes: analysis of databases. US Department of Transportation. Accessed August 29, 2023. https:\/\/rosap.ntl.bts.gov\/view\/dot\/1836"},{"key":"zoi231024r33","unstructured":"American Hospital Formulary Service. AHFS pharmacologic-therapeutic classification system. Accessed August 29, 2023. https:\/\/www.ashp.org\/products-and-services\/database-licensing-and-integration\/ahfs-therapeutic-classification"},{"key":"zoi231024r34","unstructured":"US Food and Drug Administration. Some medicines and driving don\u2019t mix. Accessed April 19, 2023. https:\/\/www.fda.gov\/consumers\/consumer-updates\/some-medicines-and-driving-dont-mix"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2809967\/carr_2023_oi_231024_1697557853.17919.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T15:00:37Z","timestamp":1698246037000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2809967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.35651","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}